Columbia Threadneedle Investments just dropped six new ETFs into the market, and the lineup tells you pretty much everything about where asset management is headed in 2025. Five of the six are actively managed, which would have been borderline weird a decade ago but now feels almost expected. Active ETFs have gone from curiosity to core product faster than most people anticipated, and Columbia Threadneedle is leaning hard into that shift.
The basic pitch here is that not all stocks deserve to be in your portfolio, even if they're in the index. These funds are designed to leverage Columbia Threadneedle's research team to make actual decisions about what to own and what to skip, rather than just mirroring a benchmark and calling it a day. And with a softer U.S. dollar and growing interest in international equities, the timing makes sense.
Research-Driven Equity Funds That Say No
On the equity side, Columbia Threadneedle is expanding its Research Enhanced series with three new funds. The idea behind these isn't revolutionary, but it's smart: instead of owning every stock in an index regardless of quality, these strategies aim to weed out the companies where the research team sees limited upside. Advisors have been complaining for years that traditional index funds carry dead weight, and this is one answer to that problem.
The Columbia Research Enhanced Small Cap ETF (RESM) and Columbia Research Enhanced Mid Cap ETF (REMC) are both actively managed and focused on finding companies with durable growth potential in their respective segments. Then there's the Columbia Research Enhanced International Equity ETF (REFA), which takes a rules-based approach tied to the Beta Advantage Research Enhanced International Equity Index. That one screens for reasonably priced global stocks with solid return profiles, giving investors exposure to overseas markets without the usual indexing baggage.
Fixed Income That Goes Beyond Basics
Columbia Threadneedle is also making a push into fixed income, which has been pulling in serious ETF inflows as investors hunt for yield and some semblance of stability. The Columbia Corporate Bond ETF (CCRP) targets investment-grade issuers, while the Columbia Core Plus Bond ETF (CRXP) casts a wider net across the U.S. bond market with flexibility for tactical adjustments when opportunities arise.
The most specialized offering in the bunch is the Columbia AAA CLO ETF (AAAC), which zeroes in on top-rated tranches of collateralized loan obligations. CLOs aren't exactly household names, but there's growing appetite for higher-quality structured credit, and this fund is positioned to meet that demand.
Marc Zeitoun, head of North America Product and Business Intelligence at Columbia Threadneedle, framed the launch around a straightforward philosophy: alpha doesn't just appear out of thin air. The firm is betting that investors increasingly want ETFs that do some thinking upfront, filtering out noise and focusing on conviction calls rather than passively holding everything. It's active management packaged for the ETF era, and judging by how quickly this space is growing, they're probably not wrong.
